BioengineeringbioRxivPreprint
Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma
Qiyan Wang, Ting Su, Furong Cheng…·Guizhi Zhu
This paper introduces PROTAVs, a new vaccine strategy that enhances T cell responses and combination immunotherapy for melanoma by improving antigen processing and cross-presentation.
1 citation